Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

A new microneedle patch made from hair proteins helps regrow hair faster and better than current treatments.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Minoxidil may cause heart changes; use caution and monitor patients with heart conditions.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Nanoparticles can speed up wound healing and deliver drugs effectively but may have potential toxicity risks.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Mutant mice help researchers understand hair growth and related genetic factors.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Minoxidil may cause heart issues in animals and humans.

Minoxidil helps prevent stress-caused hair loss in mice.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Norwegian puffin dogs have a unique type of hair loss that often doesn't get better on its own and responds well to ciclosporin treatment.

Examining scalp biopsies in different ways helps better diagnose hair loss types.

Gray hair can potentially be reversed, leading to new treatments.